Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever

These companies have what it takes to stand the test of time in a portfolio. 1. Vertex Pharmaceuticals The company has its sights set on the launch of several potential blockbusters before the end of the decade. These include a new triple-combination therapy for cystic fibrosis, which was just granted priority review by the U.S. Food and Drug Administration with a Prescription Drug User Fee Act (PDUFA) target action date of Jan. 2, 2025. No industry is totally impervious to market dynamics, but healthcare c ...